U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C17H11ClNO2S.Ca
Molecular Weight 697.663
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FENTIAZAC CALCIUM

SMILES

[Ca++].[O-]C(=O)CC1=C(N=C(S1)C2=CC=CC=C2)C3=CC=C(Cl)C=C3.[O-]C(=O)CC4=C(N=C(S4)C5=CC=CC=C5)C6=CC=C(Cl)C=C6

InChI

InChIKey=WGCKYSZZBQAHJJ-UHFFFAOYSA-L
InChI=1S/2C17H12ClNO2S.Ca/c2*18-13-8-6-11(7-9-13)16-14(10-15(20)21)22-17(19-16)12-4-2-1-3-5-12;/h2*1-9H,10H2,(H,20,21);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula C17H11ClNO2S
Molecular Weight 328.793
Charge -1
Count
MOL RATIO 2 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Ca
Molecular Weight 40.078
Charge 2
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Fentiazac is a non-steroidal anti-inflammatory agent developed for the treatment of pain disorders. The drug was marketed under the name Norvedan, however, its current marketing status is unknown and supposed to be "discontinued".

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
NORVEDAN

PubMed

Sample Use Guides

In Vivo Use Guide
6,44 mg/kg as a daily dose.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
87K2GQ2Q21
Record Status Validated (UNII)
Record Version